18F-Fluorocholine PET/CT in Medullary Thyroid Cancer

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

NCT02856347 ·Status: COMPLETED ·Phase: NA

Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer

NCT00647140 ·Status: TERMINATED ·Phase: PHASE2

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

NCT03196518 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

NCT05534594 ·Status: COMPLETED ·Phase: NA

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

NCT05575440 ·Status: RECRUITING

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

NCT01666353 ·Status: COMPLETED ·Phase: EARLY_PHASE1

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

NCT00775268 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

NCT04340765 ·Status: COMPLETED ·Phase: NA

Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma

NCT01374659 ·Status: UNKNOWN

18F-FSPG PET/CT Imaging in Patients With Cancers

NCT03144622 ·Status: UNKNOWN

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases

NCT04410133 ·Status: COMPLETED ·Phase: PHASE3

Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01179360 ·Status: COMPLETED

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090 ·Status: RECRUITING

18F-FSPG PET/CT for Cancer Patients on Therapy

NCT02599194 ·Status: COMPLETED ·Phase: PHASE2

Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer

NCT00245349 ·Status: COMPLETED

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148 ·Status: RECRUITING

The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas

NCT04570033 ·Status: COMPLETED ·Phase: NA

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

NCT04510311 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study

NCT06753513 ·Status: NOT_YET_RECRUITING

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

NCT04252859 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma

NCT01943097 ·Status: UNKNOWN

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma

NCT06737835 ·Status: NOT_YET_RECRUITING